Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Robin Young, CEO, Amur Minerals #AMC talks long-term strategy


Scancell Holdings Share Price (SCLP)



Share Price Information for Scancell Holdings (SCLP)


Share Price: 14.25Bid: 14.00Ask: 14.50Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 0.50Spread as %: 3.57%Open: 14.25High: 14.25Low: 14.25Yesterday’s Close: 14.25

Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
14.25
Share Price SpacerBid
14.00
Share Price SpacerAsk
14.50
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
30,810
Share Price SpacerOpen
14.25
Share Price SpacerHigh
14.25
Share Price SpacerLow
14.25
Share Price SpacerClose
14.25
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 384.61m £54.81m 10,000

52 Week High 19.25 52 Week High Date 12-MAR-2018
52 Week Low 9.75 52 Week Low Date 6-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
8 40,810 0 -10.478 -1.36 0.00 0.00


London South East Users info for Scancell Holdings




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

25-May-18
16:23:59
14.00
2,500
Sell* 
14.00
14.50
350.00
Trade Type:
Ordinary

25-May-18
15:43:00
14.00
2,000
Sell* 
14.00
14.50
280.00
Trade Type:
Ordinary

25-May-18
13:32:50
14.19
6,176
Sell* 
14.00
14.50
876.37
Trade Type:
Ordinary




View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-May-17Placing
Trade Notifier Information for Scancell Holdings
John Chiplin held the position of Non-Executive Director at Scancell Holdings at the time of this trade.
 John Chiplin
10GBX1,041,1771100000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
View more Scancell Holdings directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Fri 23:11CHELSEA7RE: SCLP14.25Strong Buy
Ruck that is what i was trying to get over. Just to put yourself in the situation. The first thought that sprung to mind was how lucky to even consider it could happen and the thought was firmly in place after seeing agemas take on it over on ADVFN.....................................

agema24 May '18 - 07:58 - 15790 of 15831
0 1 0
I see Modi-1 trials will not begin until the first half of next year. So could still be a year away. More jam tomorrow.

More jam tomorrow eh, to even have… Read More
Fri 15:15inanacoRE: Great news for us14.25No Opinion
the clinical data will do that once in trial ..
Fri 15:10MattRempitRE: Great news for us14.25Strong Buy
Interesting, thanks.
I guess if AstraZeneca specifically, were seen to show any interest in Scancell as of now then that could be a catalyst for some rapid upward movement in our share price.
Wishful thinking on my part I know, but if the city catch wind of any interest we could move very quickly.
Let's go Scancell, get that message out there to all.
Fri 14:52inanacoRE: Great news for us14.25No Opinion
from a science point the immunopbody platform will work with any Pd1 type products, Thus it creates more demand for vaccine's of which few manufacturers have shown efficacy because of not generating the right kind of T cell.

which is why its significant for us.

the coming SCIB1 plus Keytruda trial really is the Key to unlocking the enormous commercial IP potential of immunobody.
Fri 14:24MattRempitRE: Great news for us14.25Strong Buy
In theory, is that something you think we could tie in with Inanaco?
Fri 13:55inanacoGreat news for us14.25No Opinion
AstraZeneca capped its big win on the landmark PACIFIC study today with the news that its PD-L1 checkpoint Imfinzi delivered a statistically significant improvement in overall survival for a key segment of the lung cancer market.

competition in the lung cancer market

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Scancell Holdings (SCLP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.